Clinical Trial

Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

Study acronym: SomaScreen
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
People with severe mental illness have a substantially increased risk of undiagnosed and insufficiently treated somatic disease. Somatic Screening in the Capital Region Mental Health Service in Denmark (SomaScreen) is a service-level intervention implemented in psychiatric outpatient clinics in the Capital Region of Denmark to improve the detection and follow-up of somatic disease among patients with psychotic and affective disorders. This study evaluates whether integrating structured somatic screening into mental health services leads to improved identification and management of somatic disease compared with care as usual. Using a quasi-experimental controlled design with a matched cohort, outcomes among patients exposed to the SomaScreen intervention are compared with those of patients receiving usual care in comparable psychiatric outpatient clinics outside the Capital Region.
Trial Details
NCT Number NCT07518446
Lead Sponsor Amager Hospital
Conditions Atrial Fibrillation (AF), Heart Failure, Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Diabetes, Cancer, Psychiatric Patients, Serious Medical Illness
Enrollment 2,800 participants
Start Date 2024-09-01
Primary Completion 2026-04-30 (estimated)
Study Completion 2028-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-08